Adaptation of human CD4+ T cells to pathophysiological hypoxia: A transcriptome analysis

Journal of Rheumatology

Volumn 36, Issue 12, 2009, Pages 2655-2669

  Gaber, Timo ^a   Häupl, Thomas ^a   Sandig, Grit ^a   Tykwinska, Karolina ^a   Fangradt, Monique ^a   Tschirschmann, Miriam ^b   Hahne, Martin ^a   Dziurla, René ^a   Erekul, Kerem ^a   Lautenbach, Martin ^c   Kolar, Paula ^a   Burmester, Gerd Rüdiger ^a   Buttgereit, Frank ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

^c MARTIN LUTHER KRANKENHAUS   (Germany)

Author keywords

Hypoxia; Rheumatoid arthritis; T lymphocytes; Transcriptome

Indexed keywords

COMPLEMENTARY DNA; CYCLOHEXIMIDE; DACTINOMYCIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TRANSCRIPTOME;

ADAPTATION; ARTICLE; CD4+ T LYMPHOCYTE; CHRONIC DISEASE; CONTROLLED STUDY; GENE CLUSTER; GENE EXPRESSION; GENOME ANALYSIS; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MICROARRAY ANALYSIS; OXYGEN TENSION; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

ANIMALS; ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; CELL HYPOXIA; CELLS, CULTURED; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICROARRAY ANALYSIS; OXYGEN; SYNOVIAL MEMBRANE;

EID: 72449133970     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090255     Document Type: Article

References (51)

1. Lundquist L. Abatacept: a novel therapy approved for the treatment of patients with rheumatoid arthritis. Adv Ther 2007;24:333-345 (Pubitemid 46988377)
2. Skapenko A, Leipe J, Lipsky PE, Schulze-Koops H. The role of the T cell in autoimmune inflammation. Arthritis Res Ther 2005;7 Suppl 2:S4-14.
3. Cope AP, Schulze-Koops H, Aringer M. The central role of T cells in rheumatoid arthritis. Clin Exp Rheumatol 2007;25 Suppl:S4-11.
4. Atkuri KR, Herzenberg LA, Herzenberg LA. Culturing at atmospheric oxygen levels impacts lymphocyte function. Proc Natl Acad Sci USA 2005;102:3756-3759
5. Atkuri KR, Herzenberg LA, Niemi AK, Cowan T, Herzenberg LA. Importance of culturing primary lymphocytes at physiological oxygen levels. Proc Natl Acad Sci USA 2007;104:4547-4552 (Pubitemid 47186262)
6. Baugh JA, Gantier M, Li L, Byrne A, Buckley A, Donnelly SC. Dual regulation of macrophage migration inhibitory factor (MIF) expression in hypoxia by CREB and HIF-1. Biochem Biophys Res Commun 2006;347:895-903. (Pubitemid 44118203)
7. Liu Y, Cox SR, Morita T, Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ Res 1995;77:638-643
8. Hayashi M, Sakata M, Takeda T, Yamamoto T, Okamoto Y, Sawada K, et al. Induction of glucose transporter 1 expression through hypoxia-inducible factor 1 alpha under hypoxic conditions in trophoblast-derived cells. J Endocrinol 2004;183:145-154 (Pubitemid 40124651)
9. Firth JD, Ebert BL, Pugh CW, Ratcliffe PJ. Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3′ enhancer. Proc Natl Acad Sci USA 1994;91:6496-6500
10. Semenza GL, Roth PH, Fang HM, Wang GL. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 1994;269:23757-23763
11. Gaber T, Dziurla R, Tripmacher R, Burmester GR, Buttgereit F. Hypoxia inducible factor (HIF) in rheumatology: low O2! See what HIF can do! Ann Rheum Dis 2005;64:971-980
12. Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, et al. HIF-1 alpha is essential for myeloid cell-mediated inflammation. Cell 2003;112:645-657 (Pubitemid 36331777)
13. Makino Y, Nakamura H, Ikeda E, Ohnuma K, Yamauchi K, Yabe Y, et al. Hypoxia-inducible factor regulates survival of antigen receptor-driven T cells. J Immunol 2003;171:6534-6540 (Pubitemid 37532083)
14. Caldwell CC, Kojima H, Lukashev D, Armstrong J, Farber M, Apasov SG, et al. Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J Immunol 2001;167:6140-6149 (Pubitemid 33081540)
15. Haddad JJ. Hypoxia and the regulation of mitogen-activated protein kinases: gene transcription and the assessment of potential pharmacologic therapeutic interventions. Int Immunopharmacol 2004;4:1249-1285
16. Tripmacher R, Gaber T, Dziurla R, Haupl T, Erekul K, Grutzkau A, et al. Human CD4(+) T cells maintain specific functions even under conditions of extremely restricted ATP production. Eur J Immunol 2008;38:1631-1642
17. Bramlage CP, Haupl T, Kaps C, Ungethum U, Krenn V, Pruss A, et al. Decrease in expression of bone morphogenetic proteins 4 and 5 in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Arthritis Res Ther 2006;8:R58.
18. Haupl T, Ostensen M, Grutzkau A, Burmester GR, Villiger PM. Interaction between rheumatoid arthritis and pregnancy: correlation of molecular data with clinical disease activity measures. Rheumatology 2008;47 Suppl:iii19-22.
19. Chowdhury R, Hardy A, Schofield CJ. The human oxygen sensing machinery and its manipulation. Chem Soc Rev 2008;37:1308-1319
20. Harris AL. Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2002;2:38-47. (Pubitemid 37328806)
21. Thomas PD, Campbell MJ, Kejariwal A, Mi H, Karlak B, Daverman R, et al. PANTHER: a library of protein families and subfamilies indexed by function. Genome Res 2003;13:2129-2141 (Pubitemid 37161770)
22. Morgan E, Varro R, Sepulveda H, Ember JA, Apgar J, Wilson J, et al. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin Immunol 2004;110:252-266 (Pubitemid 38402005)
23. National Center for Biotechnology Information (NCBI) UNLoMN. NCBI GenBank entries of Homo Sapiens (human). Sep 01, 2008.
24. Bosco MC, Puppo M, Santangelo C, Anfosso L, Pfeffer U, Fardin P, et al. Hypoxia modifies the transcriptome of primary human monocytes: modulation of novel immune-related genes and identification of CC-chemokine ligand 20 as a new hypoxia-inducible gene. J Immunol 2006;177:1941-1955 (Pubitemid 44092535)
25. Chi JT, Wang Z, Nuyten DS, Rodriguez EH, Schaner ME, Salim A, et al. Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med 2006;3:e47.
26. Lee YA, Kim JY, Hong SJ, Lee SH, Yoo MC, Kim KS, et al. Synovial proliferation differentially affects hypoxia in the joint cavities of rheumatoid arthritis and osteoarthritis patients. Clin Rheumatol 2007;26:2023-2029
27. Giatromanolaki A, Sivridis E, Maltezos E, Athanassou N, Papazoglou D, Gatter KC, et al. Upregulated hypoxia inducible factor-1 alpha and -2 alpha pathway in rheumatoid arthritis and osteoarthritis. Arthritis Res Ther 2003;5:R193-201.
28. Maher JC, Wangpaichitr M, Savaraj N, Kurtoglu M, Lampidis TJ. Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucose. Mol Cancer Ther 2007;6:732-741 (Pubitemid 46332474)
29. Sitkovsky M, Lukashev D. Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat Rev Immunol 2005;5:712-721 (Pubitemid 43086172)
30. Giatromanolaki A, Sivridis E, Kouskoukis C, Gatter KC, Harris AL, Koukourakis MI. Hypoxia-inducible factors 1 alpha and 2 alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin. Melanoma Res 2003;13:493-501. (Pubitemid 37266952)
31. Hollander AP, Corke KP, Freemont AJ, Lewis CE. Expression of hypoxia-inducible factor 1 alpha by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. Arthritis Rheum 2001;44:1540-1544
32. Nakamura H, Makino Y, Okamoto K, Poellinger L, Ohnuma K, Morimoto C, et al. TCR engagement increases hypoxia-inducible factor-1 alpha protein synthesis via rapamycin-sensitive pathway under hypoxic conditions in human peripheral T cells. J Immunol 2005;174:7592-7599 (Pubitemid 40806263)
33. Lukashev D, Caldwell C, Ohta A, Chen P, Sitkovsky M. Differential regulation of two alternatively spliced isoforms of hypoxia-inducible factor-1 alpha in activated T lymphocytes. J Biol Chem 2001;276:48754-48763 (Pubitemid 37370572)
34. Lukashev D, Klebanov B, Kojima H, Grinberg A, Ohta A, Berenfeld L, et al. Cutting edge: hypoxia-inducible factor 1 alpha and its activation-inducible short isoform I.1 negatively regulate functions of CD4+ and CD8+ T lymphocytes. J Immunol 2006;177:4962-4965 (Pubitemid 44527564)
35. Thiel M, Caldwell CC, Kreth S, Kuboki S, Chen P, Smith P, et al. Targeted deletion of HIF-1 alpha gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival. PLoS One 2007;2:e853.
36. Chun YS, Choi E, Kim TY, Kim MS, Park JW. A dominant-negative isoform lacking exons 11 and 12 of the human hypoxia-inducible factor-1 alpha gene. Biochem J 2002;362:71-79 (Pubitemid 34174463)
37. Chun YS, Choi E, Yeo EJ, Lee JH, Kim MS, Park JW. A new HIF-1 alpha variant induced by zinc ion suppresses HIF-1-mediated hypoxic responses. J Cell Sci 2001;114:4051-4061 (Pubitemid 33115026)
38. Chun YS, Lee KH, Choi E, Bae SY, Yeo EJ, Huang LE, et al. Phorbol ester stimulates the nonhypoxic induction of a novel hypoxia-inducible factor 1 alpha isoform: implications for tumor promotion. Cancer Res 2003;63:8700-8707 (Pubitemid 38064047)
39. Gothie E, Richard DE, Berra E, Pages G, Pouyssegur J. Identification of alternative spliced variants of human hypoxia-inducible factor-1 alpha. J Biol Chem 2000;275:6922-6927 (Pubitemid 30146234)
40. Lukashev D, Sitkovsky M. Preferential expression of the novel alternative isoform I.3 of hypoxia-inducible factor 1 alpha in activated human T lymphocytes. Hum Immunol 2008;69:421-425
41. Roiniotis J, Dinh H, Masendycz P, Turner A, Elsegood CL, Scholz GM, et al. Hypoxia prolongs monocyte/macrophage survival and enhanced glycolysis is associated with their maturation under aerobic conditions. J Immunol 2009;182:7974-7981
42. Kojima H, Gu H, Nomura S, Caldwell CC, Kobata T, Carmeliet P, et al. Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1 alpha-deficient chimeric mice. Proc Natl Acad Sci USA 2002;99:2170-2174 (Pubitemid 34169033)
43. Kojima H, Sitkovsky MV, Cascalho M. HIF-1 alpha deficiency perturbs T and B cell functions. Curr Pharm Des 2003;9:1827-1832 (Pubitemid 37010086)
44. Ayoub S, Hickey MJ, Morand EF. Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis. Nat Clin Pract Rheumatol 2008;4:98-105.
45. Szigligeti P, Neumeier L, Duke E, Chougnet C, Takimoto K, Lee SM, et al. Signalling during hypoxia in human T lymphocytes - critical role of the src protein tyrosine kinase p56Lck in the O2 sensitivity of Kv1.3 channels. J Physiol 2006;573:357-370 (Pubitemid 43871053)
46. Sidiropoulos PI, Goulielmos G, Voloudakis GK, Petraki E, Boumpas DT. Inflammasomes and rheumatic diseases: evolving concepts. Ann Rheum Dis 2008;67:1382-1389
47. Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S. Type 17 T helper cells - origins, features and possible roles in rheumatic disease. Nat Rev Rheumatol 2009;5:325-331
48. Kishimoto T. Interleukin-6: from basic science to medicine - 40 years in immunology. Annu Rev Immunol 2005;23:1-21. (Pubitemid 40563163)
49. Lard LR, Roep BO, Toes RE, Huizinga TW. Enhanced concentrations of interleukin 16 are associated with joint destruction in patients with rheumatoid arthritis. J Rheumatol 2004;31:35-39 (Pubitemid 38067519)
50. Nowell MA, Richards PJ, Fielding CA, Ognjanovic S, Topley N, Williams AS, et al. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 2006;54:2084-2095 (Pubitemid 44051064)
51. Rodenburg RJ, van den Hoogen FH, Barrera P, van Venrooij WJ, van de Putte LB. Superinduction of interleukin 8 mRNA in activated monocyte derived macrophages from rheumatoid arthritis patients. Ann Rheum Dis 1999;58:648-652 (Pubitemid 29468035)